TipRanks
Crispr Therapeutics AG (DE:1CG)
FRANKFURT:1CG
Germany Market
1CG
Crispr Therapeutics AG
RESEARCH TOOLSreports

Crispr Therapeutics AG (1CG) Balance Sheet

22 Followers

Crispr Therapeutics AG Balance Sheet

Crispr Therapeutics AG's total assets for Q2 2026 were $2.65B, a decrease of -2.75% from the previous quarter. DE:1CG total liabilities were $904.22M for the fiscal quarter, a -0.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 2.27B$ 2.24B$ 2.23B$ 2.24B$ 2.75B
Total Liabilities
$ 343.43M$ 309.95M$ 346.77M$ 367.58M$ 352.42M
Total Equity Gross Minority
$ 1.92B$ 1.93B$ 1.88B$ 1.88B$ 2.40B
Other Metrics
Currency in USD

Crispr Therapeutics AG Debt to Assets